Teva Makes Two Inhalers Free For Charity Amid Ongoing Patent Battle With Amneal
The Patient Access Program Is Planned To Run For At Least Three Years
Teva vows to make two of its inhalers more accessible in the US through charity Direct Relief, despite still being tangled up in a lawsuit with Amneal over ProAir HFA. Also, another inhaler maker GSK is scrutinized over its pricey authorized generic alternative.
